Know-How License Agreement
Drafts a commercially balanced agreement licensing confidential technical knowledge, processes, and trade secrets — information deriving value from secrecy rather than patent disclosure.
Prerequisites
Collect before drafting:
- Transaction documents — term sheets, LOIs, prior agreements with negotiated terms
- Party information — legal names, entity types, jurisdictions, principal places of business
- Technical description — functional description of know-how sufficient to define scope without disclosing secrets
- Commercial terms — exclusivity, territory, field of use, financial structure, milestones
- Regulatory context — export control applicability, industry-specific regulations
Quick Start
- Extract deal terms from uploaded documents (see Document Review)
- Draft agreement sections in order (see Agreement Sections)
- Bracket undecided terms:
[AMOUNT], [PERIOD], [JURISDICTION]
- Validate against Drafting Checks
Document Review
Extract from uploaded documents before drafting:
| Extract |
Details |
| Party identities |
Legal names, entity types, jurisdictions |
| Know-how description |
Technical scope, functional categories — preserve negotiated language |
| Financial terms |
Upfront fees, milestones, royalty rates, minimums |
| Exclusivity & territory |
Exclusive/sole/non-exclusive, geographic scope, field of use |
| Special provisions |
Regulatory requirements, cross-border issues, university-to-industry terms |
| Existing relationships |
Prior agreements to reference or supersede |
Adjust approach for context: university-to-industry, cross-border, regulated technology, startup vs. established entity.
Agreement Sections
Draft these sections in order.
1. Preamble & Recitals
- Full party identification with entity type, jurisdiction, principal place of business
- Recitals: licensor ownership, trade secret status, licensee's desire for rights, mutual intent — no promotional language
- Reference background context (prior collaborations, strategic objectives)
2. Definitions
Precision is critical — ambiguity destroys enforceability and trade secret protection.
Key terms: Know-How/Licensed Technology (specific enough to enforce, flexible for updates; use confidential technical schedule if needed) · Licensed Territory (geographic precision; subcategories if rights vary) · Field of Use (applications, industries, product categories with clear boundaries) · Confidential Information (broad capture + standard exclusions: public domain, independent development, prior knowledge, third-party receipt) · Improvements/Derivative Know-How (modifications only vs. related developments) · Net Sales (inclusions/exclusions, bundled product valuation, affiliate transfer pricing) · Affiliate · Milestone Events (objective triggering criteria)
3. Grant of License
- Specify exclusive / sole / non-exclusive — define each in context
- Enumerate rights: use, manufacture, have-made, sell, distribute, create derivatives, sublicense
- Field-of-use restrictions with clear boundaries
- Territorial scope: manufacturing, use, sale, import; cross-border treatment
- Improvements: ownership, grant-back (exclusive/non-exclusive, royalty-bearing/free), joint improvements
- Licensor reservations: research rights, existing obligations, competing technology development
- Sublicensing: scope, approval rights, required terms, termination treatment
4. Financial Terms
| Component |
Key provisions |
| Upfront fees |
Amount, timing, conditions precedent, creditability against royalties |
| Milestones |
Defined events, objective criteria, amounts, payment timing |
| Running royalties |
% of Net Sales or per-unit; bundled product allocation; stacking discounts |
| Minimum annual royalties |
Amount per year; shortfall consequence (conversion, termination, or pay-up) |
| Payment mechanics |
Currency, FX rates, frequency, method, late interest |
| Records & audit |
3–5 year retention; annual audit by independent CPA; cost-shifting if underpayment exceeds threshold |
5. Confidentiality & Trade Secret Protection
Failure here destroys trade secret status — this section is outcome-determinative.
- Standard of care: at least same as own most sensitive information, no less than reasonable care
- Physical, technical, and administrative safeguards required
- Permitted disclosures: need-to-know only, written confidentiality agreements from recipients
- Written disclosure log maintained; available to licensor on request
- Compelled disclosure: prompt notice, cooperate on protective orders, minimum disclosure
- Survival: indefinite (until public domain through no breach)
- Return/destruction on termination with officer certification
- Residual knowledge: address explicitly — cessation + destruction, or continued use subject to ongoing confidentiality and royalties (most litigated post-termination issue)
6. Technology Transfer & Support
- Documentation deliverables: format, scope, timeline
- Training: sessions, duration, location, cost allocation
- Ongoing technical support: scope, response times, limitations
- Manufacturing transfer, process validation, regulatory support
- Quality control: standards, sampling, reporting, facility inspections
- Updates/improvements: obligation to provide, included vs. additional fee
7. Diligence & Performance
Required for exclusive licenses — include objective milestones.
- Commercially reasonable efforts obligation
- Specific milestones with deadlines (development, regulatory, first commercial sale, sales targets)
- Consequences for failure: conversion to non-exclusive, termination, compulsory sublicensing
- Periodic progress reports: frequency, content, timing
8. Representations & Warranties
Licensor: authority to grant license, ownership/control of know-how, trade secret status maintained, no known third-party infringement (knowledge qualifier), disclosure of known limitations.
Licensee: authority to enter agreement, lawful use and regulatory compliance, technical and financial capability, export control and anti-corruption compliance.
Disclaimers (conspicuous text — bold or caps): AS-IS for functionality/accuracy/completeness/fitness, no non-infringement warranty (licensee responsible for FTO), disclaim implied warranties of merchantability and fitness for particular purpose.
9. Indemnification
- Licensee indemnifies: use, modification, manufacture, sale; product liability; combination with other tech; failure to follow instructions
- Licensor indemnifies: third-party IP claims re know-how as provided (often limited to rep/warranty breach)
- Procedures: prompt notice, indemnifier controls defense, no settlement admitting liability without consent, late notice relieves only to extent of material prejudice
10. Limitation of Liability
- Mutual consequential damages waiver (conspicuous text)
- Aggregate cap (e.g., multiple of fees paid in preceding 12 months)
- Carve-outs: confidentiality breach, unauthorized use beyond scope, indemnification, willful misconduct, gross negligence, fraud
11. IP Ownership
- Licensor retains all rights in licensed know-how; licensee acquires only expressly granted rights
- Improvements: licensor-developed → licensor; licensee-developed → licensee (subject to grant-back); joint → per agreement
- Enforcement: primary enforcer, notice obligations, cost/recovery allocation, step-in rights
12. Term & Termination
| Trigger |
Provisions |
| Term |
Perpetual, fixed, or until terminated; renewal mechanics |
| Convenience |
30–180 days notice; consider restricting for exclusive licenses |
| Material breach |
Written notice + 30–60 day cure period |
| Incurable breach |
Immediate: confidentiality breach, unauthorized use, non-payment |
| Insolvency |
Automatic on bankruptcy, receivership, assignment for creditors |
| Diligence failure |
Conversion to non-exclusive or termination |
| Change of control |
Termination right, especially if acquirer is competitor |
13. Post-Termination
- Cessation of use (immediate or wind-down with continued royalties)
- Sublicense treatment: automatic termination, survival if compliant, or conversion to direct license
- Return/destruction of all materials with written certification
- Accrued payments immediately due; audit rights survive
- Survival: confidentiality, payment, indemnification, liability limits, dispute resolution, governing law
14. Regulatory & Export Control
- Compliance with EAR, ITAR, and equivalent foreign laws
- Licensee responsible for export licenses/approvals
- No transfer to prohibited destinations/entities/persons
- Industry-specific compliance (FDA, environmental, safety) — allocate regulatory approval responsibility
15. General Provisions
Entire agreement, amendment (written only), assignment restrictions (consent required; affiliate/successor exceptions), notices, severability, waiver (written, instance-specific), independent contractor, counterparts/e-signatures (E-SIGN Act), force majeure (excludes payment; termination if prolonged), further assurances.
16. Signature Blocks & Schedules
Signature blocks with name, title, date, authority representation. Exhibits: confidential technical description, documentation list, payment schedule, milestone chart, quality specs, form sublicense/NDA.
Drafting Checks
- Calibrate to deal size: complex/high-value → exhaustive schedules; simple methodology transfer → streamlined
- Protect trade secret status: every confidentiality provision must satisfy DTSA/UTSA requirements
- No implied licenses: expressly reserve all rights not granted
- Conspicuous disclaimers: bold or caps for warranty disclaimers and liability limitations
- Export control: mandatory for any dual-use technology
- Royalty stacking: include anti-stacking or reduction provisions if applicable
- Exclusive licenses: always require diligence with objective milestones
- Jurisdictional flags: note where provisions need non-US adjustment
1---2name: know-how-license3description: Drafts Know-How License Agreements for licensing trade secrets, confidential processes, and proprietary methodologies where value derives from secrecy rather than patents. Reviews transaction documents to extract deal terms, financial structures, and exclusivity provisions. Use when drafting know-how licenses, trade secret licenses, technology transfer agreements, or confidential information licensing agreements.4---5
6# Know-How License Agreement
7
8Drafts a commercially balanced agreement licensing confidential technical knowledge, processes, and trade secrets — information deriving value from secrecy rather than patent disclosure.
9
10## Prerequisites
11
12Collect before drafting:
13
141. **Transaction documents** — term sheets, LOIs, prior agreements with negotiated terms
152. **Party information** — legal names, entity types, jurisdictions, principal places of business
163. **Technical description** — functional description of know-how sufficient to define scope without disclosing secrets
174. **Commercial terms** — exclusivity, territory, field of use, financial structure, milestones
185. **Regulatory context** — export control applicability, industry-specific regulations
19
20## Quick Start
21
221. Extract deal terms from uploaded documents (see Document Review)
232. Draft agreement sections in order (see Agreement Sections)
243. Bracket undecided terms: `[AMOUNT]`, `[PERIOD]`, `[JURISDICTION]`
254. Validate against Drafting Checks
26
27## Document Review
28
29Extract from uploaded documents before drafting:
30
31| Extract | Details |
32|---------|---------|
33| Party identities | Legal names, entity types, jurisdictions |
34| Know-how description | Technical scope, functional categories — preserve negotiated language |
35| Financial terms | Upfront fees, milestones, royalty rates, minimums |
36| Exclusivity & territory | Exclusive/sole/non-exclusive, geographic scope, field of use |
37| Special provisions | Regulatory requirements, cross-border issues, university-to-industry terms |
38| Existing relationships | Prior agreements to reference or supersede |
39
40Adjust approach for context: university-to-industry, cross-border, regulated technology, startup vs. established entity.
41
42## Agreement Sections
43
44Draft these sections in order.
45
46### 1. Preamble & Recitals
47
48- Full party identification with entity type, jurisdiction, principal place of business
49- Recitals: licensor ownership, trade secret status, licensee's desire for rights, mutual intent — no promotional language
50- Reference background context (prior collaborations, strategic objectives)
51
52### 2. Definitions
53
54Precision is critical — ambiguity destroys enforceability and trade secret protection.
55
56Key terms: **Know-How/Licensed Technology** (specific enough to enforce, flexible for updates; use confidential technical schedule if needed) · **Licensed Territory** (geographic precision; subcategories if rights vary) · **Field of Use** (applications, industries, product categories with clear boundaries) · **Confidential Information** (broad capture + standard exclusions: public domain, independent development, prior knowledge, third-party receipt) · **Improvements/Derivative Know-How** (modifications only vs. related developments) · **Net Sales** (inclusions/exclusions, bundled product valuation, affiliate transfer pricing) · **Affiliate** · **Milestone Events** (objective triggering criteria)
57
58### 3. Grant of License
59
60- Specify exclusive / sole / non-exclusive — define each in context
61- Enumerate rights: use, manufacture, have-made, sell, distribute, create derivatives, sublicense
62- Field-of-use restrictions with clear boundaries
63- Territorial scope: manufacturing, use, sale, import; cross-border treatment
64- Improvements: ownership, grant-back (exclusive/non-exclusive, royalty-bearing/free), joint improvements
65- Licensor reservations: research rights, existing obligations, competing technology development
66- Sublicensing: scope, approval rights, required terms, termination treatment
67
68### 4. Financial Terms
69
70| Component | Key provisions |
71|-----------|---------------|
72| Upfront fees | Amount, timing, conditions precedent, creditability against royalties |
73| Milestones | Defined events, objective criteria, amounts, payment timing |
74| Running royalties | % of Net Sales or per-unit; bundled product allocation; stacking discounts |
75| Minimum annual royalties | Amount per year; shortfall consequence (conversion, termination, or pay-up) |
76| Payment mechanics | Currency, FX rates, frequency, method, late interest |
77| Records & audit | 3–5 year retention; annual audit by independent CPA; cost-shifting if underpayment exceeds threshold |
78
79### 5. Confidentiality & Trade Secret Protection
80
81Failure here destroys trade secret status — this section is outcome-determinative.
82
83- Standard of care: at least same as own most sensitive information, no less than reasonable care
84- Physical, technical, and administrative safeguards required
85- Permitted disclosures: need-to-know only, written confidentiality agreements from recipients
86- Written disclosure log maintained; available to licensor on request
87- Compelled disclosure: prompt notice, cooperate on protective orders, minimum disclosure
88- Survival: indefinite (until public domain through no breach)
89- Return/destruction on termination with officer certification
90- **Residual knowledge**: address explicitly — cessation + destruction, or continued use subject to ongoing confidentiality and royalties (most litigated post-termination issue)
91
92### 6. Technology Transfer & Support
93
94- Documentation deliverables: format, scope, timeline
95- Training: sessions, duration, location, cost allocation
96- Ongoing technical support: scope, response times, limitations
97- Manufacturing transfer, process validation, regulatory support
98- Quality control: standards, sampling, reporting, facility inspections
99- Updates/improvements: obligation to provide, included vs. additional fee
100
101### 7. Diligence & Performance
102
103Required for exclusive licenses — include objective milestones.
104
105- Commercially reasonable efforts obligation
106- Specific milestones with deadlines (development, regulatory, first commercial sale, sales targets)
107- Consequences for failure: conversion to non-exclusive, termination, compulsory sublicensing
108- Periodic progress reports: frequency, content, timing
109
110### 8. Representations & Warranties
111
112**Licensor**: authority to grant license, ownership/control of know-how, trade secret status maintained, no known third-party infringement (knowledge qualifier), disclosure of known limitations.
113
114**Licensee**: authority to enter agreement, lawful use and regulatory compliance, technical and financial capability, export control and anti-corruption compliance.
115
116**Disclaimers (conspicuous text — bold or caps)**: AS-IS for functionality/accuracy/completeness/fitness, no non-infringement warranty (licensee responsible for FTO), disclaim implied warranties of merchantability and fitness for particular purpose.
117
118### 9. Indemnification
119
120- **Licensee indemnifies**: use, modification, manufacture, sale; product liability; combination with other tech; failure to follow instructions
121- **Licensor indemnifies**: third-party IP claims re know-how as provided (often limited to rep/warranty breach)
122- Procedures: prompt notice, indemnifier controls defense, no settlement admitting liability without consent, late notice relieves only to extent of material prejudice
123
124### 10. Limitation of Liability
125
126- Mutual consequential damages waiver (conspicuous text)
127- Aggregate cap (e.g., multiple of fees paid in preceding 12 months)
128- Carve-outs: confidentiality breach, unauthorized use beyond scope, indemnification, willful misconduct, gross negligence, fraud
129
130### 11. IP Ownership
131
132- Licensor retains all rights in licensed know-how; licensee acquires only expressly granted rights
133- Improvements: licensor-developed → licensor; licensee-developed → licensee (subject to grant-back); joint → per agreement
134- Enforcement: primary enforcer, notice obligations, cost/recovery allocation, step-in rights
135
136### 12. Term & Termination
137
138| Trigger | Provisions |
139|---------|-----------|
140| Term | Perpetual, fixed, or until terminated; renewal mechanics |
141| Convenience | 30–180 days notice; consider restricting for exclusive licenses |
142| Material breach | Written notice + 30–60 day cure period |
143| Incurable breach | Immediate: confidentiality breach, unauthorized use, non-payment |
144| Insolvency | Automatic on bankruptcy, receivership, assignment for creditors |
145| Diligence failure | Conversion to non-exclusive or termination |
146| Change of control | Termination right, especially if acquirer is competitor |
147
148### 13. Post-Termination
149
150- Cessation of use (immediate or wind-down with continued royalties)
151- Sublicense treatment: automatic termination, survival if compliant, or conversion to direct license
152- Return/destruction of all materials with written certification
153- Accrued payments immediately due; audit rights survive
154- Survival: confidentiality, payment, indemnification, liability limits, dispute resolution, governing law
155
156### 14. Regulatory & Export Control
157
158- Compliance with EAR, ITAR, and equivalent foreign laws
159- Licensee responsible for export licenses/approvals
160- No transfer to prohibited destinations/entities/persons
161- Industry-specific compliance (FDA, environmental, safety) — allocate regulatory approval responsibility
162
163### 15. General Provisions
164
165Entire agreement, amendment (written only), assignment restrictions (consent required; affiliate/successor exceptions), notices, severability, waiver (written, instance-specific), independent contractor, counterparts/e-signatures (E-SIGN Act), force majeure (excludes payment; termination if prolonged), further assurances.
166
167### 16. Signature Blocks & Schedules
168
169Signature blocks with name, title, date, authority representation. Exhibits: confidential technical description, documentation list, payment schedule, milestone chart, quality specs, form sublicense/NDA.
170
171## Drafting Checks
172
173- **Calibrate to deal size**: complex/high-value → exhaustive schedules; simple methodology transfer → streamlined
174- **Protect trade secret status**: every confidentiality provision must satisfy DTSA/UTSA requirements
175- **No implied licenses**: expressly reserve all rights not granted
176- **Conspicuous disclaimers**: bold or caps for warranty disclaimers and liability limitations
177- **Export control**: mandatory for any dual-use technology
178- **Royalty stacking**: include anti-stacking or reduction provisions if applicable
179- **Exclusive licenses**: always require diligence with objective milestones
180- **Jurisdictional flags**: note where provisions need non-US adjustment